THE MEDICAL NEWS

Women exposed to agricultural pesticides, even before becoming pregnant, may be putting their newborn's health at risk.

A research team led by Albert Einstein College of Medicine scientists has developed a new strategy to engineer immune cells that dramatically prolongs their effectiveness after being infused into patients to fight cancer and HIV, addressing a major limitation of current treatments.

A genetic mutation that helps animals like yaks and Tibetan antelopes survive at high altitudes may hold the key to repairing nerve damage in conditions such as cerebral paralysis and multiple sclerosis (MS).

Clinically available KRAS inhibitors mainly target G12C, which is rare in PDAC and often acquires resistance. Oncogenic KRAS inactivates RB1 via CDK4/6, while RB1 mutation is rare.

An international team of researchers has achieved a breakthrough in the production of doxorubicin, a vital chemotherapy agent.

Persons under stress may have a harder time spatially orienting themselves. Researchers in Bochum have discovered why.

Macrophages are central to mechanobiology research: their physical characteristics-stiffness, adhesion, and ECM (extracellular matrix) sensing-are inextricably linked to their phenotypic polarization and immune function.

For their discovery of genomic imprinting, developmental biologists Davor Solter and Azim Surani will receive the 2026 Paul Ehrlich and Ludwig Darmstaedter Prize, endowed with €120,000, on March 14 at Frankfurt’s Paulskirche.

Dementia, global trends, community attitudes, conscientious objections by doctors and health facilities, Indigenous perspectives, and organ donation are among agenda topics for the International Conference on Assisted Dying and Other End of Life Care (ICEL5) at QUT next month.